Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 58

1.

New highly potent and specific E6 and E7 siRNAs for treatment of HPV16 positive cervical cancer.

Yamato K, Yamada T, Kizaki M, Ui-Tei K, Natori Y, Fujino M, Nishihara T, Ikeda Y, Nasu Y, Saigo K, Yoshinouchi M.

Cancer Gene Ther. 2008 Mar;15(3):140-53. Epub 2007 Dec 21.

PMID:
18157144
2.

Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA.

Yamato K, Fen J, Kobuchi H, Nasu Y, Yamada T, Nishihara T, Ikeda Y, Kizaki M, Yoshinouchi M.

Cancer Gene Ther. 2006 Mar;13(3):234-41.

PMID:
16138119
3.

Eradication of HPV post-surgical treatments, its correlation with specific types, types of surgery and the physical status.

Fen J, Yoshinouchi M, Nakamura K, Kodama J, Nasu Y, Yamato K, Hiramatsu Y.

Oncol Rep. 2004 Aug;12(2):375-9.

PMID:
15254705
4.

Heparanase messenger RNA expression in epithelial ovarian tumor.

Kodama J, Shinyo Y, Hashen G, Hongo A, Yoshinouchi M, Hiramatsu Y.

Int J Mol Med. 2003 Dec;12(6):961-4.

PMID:
14612974
5.

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by E6 siRNA.

Yoshinouchi M, Yamada T, Kizaki M, Fen J, Koseki T, Ikeda Y, Nishihara T, Yamato K.

Mol Ther. 2003 Nov;8(5):762-8.

6.

Heparanase expression is an independent prognostic factor in patients with invasive cervical cancer.

Shinyo Y, Kodama J, Hongo A, Yoshinouchi M, Hiramatsu Y.

Ann Oncol. 2003 Oct;14(10):1505-10.

PMID:
14504050
7.

Regression of esophageal papillomatous polyposis caused by high-risk type human papilloma virus.

Kato H, Orito E, Yoshinouchi T, Ueda R, Koizumi T, Yoshinouchi M, Mizokami M.

J Gastroenterol. 2003;38(6):579-83.

PMID:
12856674
8.

[Paclitaxel and carboplatin with or without pirarubicin (THP-ADR) as first line chemotherapy in elderly patients].

Nagao S, Okimoto N, Hongo A, Mizutani Y, Kodama J, Yoshinouchi M, Hiramatsu Y, Kudo T.

Gan To Kagaku Ryoho. 2003 Feb;30(2):243-9. Japanese.

PMID:
12610873
9.

[The effect of L-Glutamine and Shakuyaku-Kanzo-to for paclitaxel-induced myalgia/arthralgia].

Hasegawa K, Mizutani Y, Kuramoto H, Nagao S, Masuyama H, Hongo A, Kodama J, Yoshinouchi M, Hiramatsu Y, Kudo T, Okuda H.

Gan To Kagaku Ryoho. 2002 Apr;29(4):569-74. Japanese.

PMID:
11977541
10.

Rapid and sensitive detection of physical status of human papillomavirus type 16 DNA by quantitative real-time PCR.

Nagao S, Yoshinouchi M, Miyagi Y, Hongo A, Kodama J, Itoh S, Kudo T.

J Clin Microbiol. 2002 Mar;40(3):863-7.

11.

Neoadjuvant treatment with docetaxel and the effects of irradiation for human ovarian adenocarcinoma and cervical squamous cell carcinoma in vitro.

Araki S, Miyagi Y, Kawanishi K, Yamamoto J, Hongo A, Kodama J, Yoshinouchi M, Kudo T.

Acta Med Okayama. 2002 Feb;56(1):13-8.

12.

Optimal surgery and diagnostic approach of stage IA2 squamous cell carcinoma of the cervix.

Kodama J, Mizutani Y, Hongo A, Yoshinouchi M, Kudo T, Okuda H.

Eur J Obstet Gynecol Reprod Biol. 2002 Mar 10;101(2):192-5.

PMID:
11858897
13.

Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.

Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H, Kudo T.

Anticancer Res. 2001 Jul-Aug;21(4B):2983-7.

PMID:
11712798
14.

Thrombospondin-1 and -2 messenger RNA expression in invasive cervical cancer: correlation with angiogenesis and prognosis.

Kodama J, Hashimoto I, Seki N, Hongo A, Yoshinouchi M, Okuda H, Kudo T.

Clin Cancer Res. 2001 Sep;7(9):2826-31.

15.

Thrombospondin-1 and -2 messenger RNA expression in normal and neoplastic endometrial tissues: correlation with angiogenesis and prognosis.

Seki N, Kodama J, Hashimoto I, Hongo A, Yoshinouchi M, Kudo T.

Int J Oncol. 2001 Aug;19(2):305-10.

PMID:
11445843
16.

Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasive cervical cancer.

Hashimoto I, Kodama J, Seki N, Hongo A, Yoshinouchi M, Okuda H, Kudo T.

Br J Cancer. 2001 Jul 6;85(1):93-7.

17.

Cytocidal effect and DNA damage of nedaplatin in vitro by simulating pharmacokinetic parameters.

Kawanishi K, Miyagi Y, Yamamoto J, Miyagi Y, Nakamura K, Kodama J, Hongo A, Yoshinouchi M, Kudo T.

Cancer Chemother Pharmacol. 2001 Apr;47(4):303-8.

PMID:
11345646
18.

Cytocidal effect and DNA damage of nedaplatin: a mathematical model and analysis of experimental data.

Miyagi Y, Kawanishi K, Miyagi Y, Yamada S, Yamamoto J, Kodama J, Hongo A, Yoshinouchi M, Kudo T.

Cancer Chemother Pharmacol. 2001 Mar;47(3):229-35.

PMID:
11320666
19.

[Concurrent chemoradiotherapy for advanced cervical cancer--a pilot study].

Kodama J, Hashimoto I, Seki N, Hongo A, Mizutani Y, Miyagi Y, Yoshinouchi M, Kudo T.

Gan To Kagaku Ryoho. 2001 Mar;28(3):351-5. Japanese.

PMID:
11265403
20.

Macrophage infiltration and angiogenesis in endometrial cancer.

Hashimoto I, Kodama J, Seki N, Hongo A, Miyagi Y, Yoshinouchi M, Kudo T.

Anticancer Res. 2000 Nov-Dec;20(6C):4853-6.

PMID:
11205231
21.

Detection of c-erbB-2 and FGF-3 (INT-2) gene amplification in epithelial ovarian cancer.

Seki A, Yoshinouchi M, Seki N, Kodama J, Miyagi Y, Kudo T.

Int J Oncol. 2000 Jul;17(1):103-6.

PMID:
10853025
22.
23.
24.

Alteration of the CDKN2/p16 gene is not required for HPV-positive uterine cervical cancer cell lines.

Yoshinouchi M, Hongo A, Takamoto N, Ono Y, Nagao S, Miyagi Y, Kudo T, Kodama J.

Int J Oncol. 2000 Mar;16(3):537-41.

PMID:
10675486
25.

Effect of cisplatin on cell death and DNA crosslinking in rat mammary. Adenocarcinoma in vitro.

Yamamoto J, Miyagi Y, Kawanishi K, Yamada S, Miyagi Y, Kodama J, Yoshinouchi M, Kudo T.

Acta Med Okayama. 1999 Oct;53(5):201-8.

PMID:
10561728
26.

Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers.

Yoshinouchi M, Hongo A, Nakamura K, Kodama J, Itoh S, Sakai H, Kudo T.

J Clin Microbiol. 1999 Nov;37(11):3514-7.

27.

Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in endometrial cancer.

Seki N, Kodama J, Hongo A, Miyagi Y, Yoshinouchi M, Kudo T.

Int J Oncol. 1999 Oct;15(4):781-6.

PMID:
10493962
28.

A rare case of solitary metastasis of cervical cancer to the colon after radiation therapy.

Kodama J, Hongo A, Mizutani Y, Miyagi Y, Yoshinouchi M, Kudo T.

Eur J Gynaecol Oncol. 1999;20(4):281-2. No abstract available.

PMID:
10475123
29.

Vascular endothelial growth factor is implicated in early invasion in cervical cancer.

Kodama J, Seki N, Tokumo K, Hongo A, Miyagi Y, Yoshinouchi M, Okuda H, Kudo T.

Eur J Cancer. 1999 Mar;35(3):485-9.

PMID:
10448304
30.

Assessment of myometrial invasion at the invasion site of an endometrial carcinoma by ultrasonography along with an intrauterine catheter.

Perdomo IA, Miyagi Y, Yamada S, Kawanishi K, Yamamoto J, Miyagi Y, Hongo A, Kodama J, Yoshinouchi M, Kobashi Y, Kudo T.

J Obstet Gynaecol Res. 1999 Apr;25(2):99-106.

PMID:
10379124
31.

Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in cervical cancer.

Kodama J, Yoshinouchi M, Seki N, Hongo A, Miyagi Y, Kudo T.

Int J Oncol. 1999 Jul;15(1):149-54.

PMID:
10375608
32.

Platelet-derived endothelial cell growth factor is not implicated in progression of cervical cancer.

Kodama J, Seki N, Tokumo K, Hongo A, Miyagi Y, Yoshinouchi M, Okuda H, Kudo T.

Oncol Rep. 1999 May-Jun;6(3):617-20.

PMID:
10203602
33.

Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer.

Kodama J, Miyagi Y, Seki N, Tokumo K, Yoshinouchi M, Kobashi Y, Okuda H, Kudo T.

Eur J Obstet Gynecol Reprod Biol. 1999 Jan;82(1):107-10.

PMID:
10192497
34.

CD44 exon v6 correlates with cellular differentiation but not with progression and metastasis of cervical cancer.

Tokumo K, Kodama J, Seki N, Miyagi Y, Yoshinouchi M, Kudo T.

Eur J Cancer. 1998 Dec;34(13):2107-11.

PMID:
10070319
35.

[Neoadjuvant chemotherapy for advanced cervical cancer].

Kodama J, Ikuhashi H, Hongo A, Mizutani Y, Miyagi Y, Yoshinouchi M, Kobashi Y, Okuda H, Kudo T.

Gan To Kagaku Ryoho. 1999 Jan;26(1):89-92. Japanese.

PMID:
9987503
36.

Reply.

Kodama J, Yoshinouchi M.

Gynecol Oncol. 1998 Jul;70(1):153.

PMID:
9698610
37.

Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes.

Kobayashi Y, Yoshinouchi M, Tianqi G, Nakamura K, Hongo A, Kamimura S, Mizutani Y, Kodama J, Miyagi Y, Kudo T.

Clin Cancer Res. 1998 Apr;4(4):979-83.

38.

CD44 exon v6 is not implicated in the progression and metastasis of endometrial cancer.

Tokumo K, Kodama J, Seki N, Miyagi Y, Yoshinouchi M, Kudo T.

Cancer Lett. 1998 Mar 13;125(1-2):221-5.

PMID:
9566719
39.

Different angiogenic pathways in human cervical cancers.

Tokumo K, Kodama J, Seki N, Nakanishi Y, Miyagi Y, Kamimura S, Yoshinouchi M, Okuda H, Kudo T.

Gynecol Oncol. 1998 Jan;68(1):38-44.

PMID:
9454658
40.

A close correlation between c-erbB-2 gene amplification and local progression in endometrial adenocarcinoma.

Seki A, Nakamura K, Kodama J, Miyagi Y, Yoshinouchi M, Kudo T.

Eur J Gynaecol Oncol. 1998;19(1):90-2.

PMID:
9476070
41.

Malignant melanoma of the uterine cervix: a case report.

Miyagi Y, Yamada S, Miyagi Y, Yamamoto J, Kawanishi K, Yoshinouchi M, Kodama J, Kamimura S, Takamoto N, Kudo T, Taguchi K.

J Obstet Gynaecol Res. 1997 Dec;23(6):511-9.

PMID:
9433042
42.

Amplification of the mdm-2 gene and p53 abnormalities in uterine sarcomas.

Seki A, Kodama J, Miyagi Y, Kamimura S, Yoshinouchi M, Kudo T.

Int J Cancer. 1997 Sep 26;73(1):33-7.

43.

The expression of vascular endothelial growth factor and transforming growth factor-beta associates with angiogenesis in epithelial ovarian cancer.

Nakanishi Y, Kodama J, Yoshinouchi M, Tokumo K, Kamimura S, Okuda H, Kudo T.

Int J Gynecol Pathol. 1997 Jul;16(3):256-62.

PMID:
9421092
44.

Immunohistochemical analysis of glutathione S-transferase mu expression in ovarian tumors.

Matsumoto T, Hayase R, Kodama J, Kamimura S, Yoshinouchi M, Kudo T.

Eur J Obstet Gynecol Reprod Biol. 1997 Jun;73(2):171-6.

PMID:
9228500
45.

Advanced endometrial cancer detected at 7 months after childbirth.

Kodama J, Yoshinouchi M, Miyagi Y, Kobashi Y, Kamimura S, Okuda H, Kudo T.

Gynecol Oncol. 1997 Mar;64(3):501-6. Review.

PMID:
9062160
46.

Placenta growth factor is abundantly expressed in human cervical squamous cell carcinoma.

Kodama J, Seki N, Tokumo K, Nakanishi Y, Yoshinouchi M, Kudo T.

Eur J Gynaecol Oncol. 1997;18(6):508-10.

PMID:
9443023
47.

Reverse correlation between P-glycoprotein expression and proliferative activity in endometrial adenocarcinoma.

Kodama J, Ryoji H, Okuda H, Yoshinouchi M, Kudo T.

Eur J Obstet Gynecol Reprod Biol. 1995 Mar;59(1):45-51.

PMID:
7781860
48.

Immunohistochemical analysis of P-glycoprotein expression in diverse histological types of epithelial ovarian tumors.

Kodama J, Hayase R, Yoshinouchi M, Okuda H, Kudo T.

Acta Med Okayama. 1994 Oct;48(5):249-55.

PMID:
7863796
49.

[Combination chemotherapy of peplomycin, vincristine, mitomycin C, and cisplatin in gynecologic carcinomas].

Tamada T, Hayase R, Seki A, Yamamoto J, Kodama J, Yoshinouchi M, Kobashi Y, Okuda H, Kudo T.

Gan To Kagaku Ryoho. 1994 Aug;21(10):1685-7. Japanese. No abstract available.

PMID:
8060147
50.

Basic fibroblast growth factor stimulates DNA synthesis in cells overexpressing the insulin-like growth factor-I receptor.

Yoshinouchi M, Miura M, Gaozza E, Li SW, Baserga R.

Mol Endocrinol. 1993 Sep;7(9):1161-8.

PMID:
8247018

Supplemental Content

Loading ...
Support Center